MAI-014
N/A
Report date: 2022/09/09 13:35:09
First In Class
Base Information
Drug NameMAI-014
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedAbome Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A